Pharmacogenetics of alcohol metabolism and alcoholismDiscovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysisAssessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelinesGenetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activityIdentification of a functionally impaired allele of human novel oxidoreductase 1 (NDOR1), NDOR1*1Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolismCharacterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseasesHuman UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergenceCalcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongationDeletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramineMolecular genetics of human aldehyde dehydrogenaseHaplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.PharmGKB summary: very important pharmacogene information for UGT1A1Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variabilityVery important pharmacogene summary: thiopurine S-methyltransferaseSubstrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductaseTwenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activityFrom mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcoticsGenome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatientsThe discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression systemCoumarins are competitive inhibitors of cytochrome P450 1B1, with equal potency for allelic variantsToxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphismPharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamicsComparison of delivery strategies for pharmacogenetic testing servicesPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6Dietary intake alters gene expression in colon tissue: possible underlying mechanism for the influence of diet on disease.PharmGKB summary: very important pharmacogene information for RYR1Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type IIHuman Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibilityAn additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansCharacterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic geneCharacterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlationMolecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoformsTwo linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humansAssociation between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mappingGenomic structure and sequence analysis of a human inositol polyphosphate 1-phosphatase gene (INPP1)Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphisms
P1433
Q22242782-8EC9E7B0-9B09-4721-A1B5-C649ECE69AC3Q22253399-7932A152-FEA4-404D-84C5-D794E49F6263Q24289170-88095E24-D1C2-4E22-A1E5-3CA49B180CFCQ24300471-78515A41-75DE-4E8C-82A6-2B4F938D0B39Q24302460-FB11FACF-ACD9-42D5-8710-43D0D99D887FQ24303317-73EAD7F1-1A83-478A-BD59-A2C5EB656D69Q24306054-8435CE66-07E6-4EC7-9EC5-E9157EABCB92Q24310887-7A04754B-63FD-498F-98E0-F57CA7C083D9Q24311466-6E1CA064-8717-4E27-825B-92B1BBC21ABCQ24315685-F4B7BD15-5370-44D8-A082-9D23920225DAQ24317369-DE9B5B52-BF4D-46A0-A3A6-4B14EC797B4FQ24324135-2F39712A-4F31-4590-A299-F40E37B7DEF3Q24539077-D7219CD6-29C0-4A5E-87F3-91D345CEB859Q24562836-33B72E9B-26F5-4CDC-9F3F-AE1948CC6964Q24596022-F5E0B25F-5149-4CA0-BBC1-E82690D09CFDQ24601748-6617F0EF-6928-4D8A-9348-25D45D385930Q24607331-294EE56C-A367-4B63-BCA4-2DD32B6EFA7AQ24643332-55D2EF76-479A-431F-A090-F43F299ACF51Q24648063-B270183A-9B21-4FEA-BC57-0CBC1F2201AAQ24650926-9BE9EC32-BBAC-418A-909F-36FF3AED1E13Q24651546-86D196F8-993E-40B7-AA44-EB4C1A9CF5C0Q24991842-0810F0DF-0A70-4415-9CC3-079E07BFE2E8Q26154276-1D234F27-0B7C-4290-A262-460DEDB1D495Q26781824-866A2492-BA06-4480-B4D4-D923936D245EQ26860925-DF0477AC-CB3B-45E5-8E7F-939459D20354Q27011622-34019A47-53DB-4B5D-B1FC-9B94DE21DC86Q27012807-125B4993-F249-42B1-9BD7-FB42D0B06FD3Q27317721-5798A5EF-928B-4534-BC0D-5378DD324F0CQ28074804-C1D72978-9427-49D1-9869-330F248D4470Q28115080-1EC16515-A53B-49D8-800E-28FC43D0CF98Q28116038-E2A03D34-D0CB-40A5-BC01-F69176D61EFBQ28137607-C696EC9C-7AB9-4943-8FAF-35AB8916B050Q28137845-DC163620-31EA-4354-AD34-74AF4EC67844Q28137968-8DFBDE68-5FA1-4045-AD55-CEC044CD03A8Q28138886-95CAE5F8-1EB3-4EA0-A619-A373D3B9B021Q28140931-DD953668-DFCA-48E2-8FB9-60D787CA1F46Q28141640-4DC10B41-CA48-430E-B879-0DFA3CF3D2B2Q28142839-C5308FB6-FC7A-47CF-8155-A001508731F5Q28142843-6371E29F-793A-48DF-9A32-251EF8578EB5Q28143557-0863BF06-FEFD-4A72-B45A-E6AB3789A258
P1433
description
Wissenschaftliche Fachzeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Lippincott Williams & Wilkins
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Pharmacogenetics and Genomics
@ast
Pharmacogenetics and Genomics
@da
Pharmacogenetics and Genomics
@de
Pharmacogenetics and Genomics
@en
Pharmacogenetics and Genomics
@es
Pharmacogenetics and Genomics
@fi
Pharmacogenetics and Genomics
@fr
Pharmacogenetics and Genomics
@it
Pharmacogenetics and Genomics
@nb
Pharmacogenetics and Genomics
@nl
type
label
Pharmacogenetics and Genomics
@ast
Pharmacogenetics and Genomics
@da
Pharmacogenetics and Genomics
@de
Pharmacogenetics and Genomics
@en
Pharmacogenetics and Genomics
@es
Pharmacogenetics and Genomics
@fi
Pharmacogenetics and Genomics
@fr
Pharmacogenetics and Genomics
@it
Pharmacogenetics and Genomics
@nb
Pharmacogenetics and Genomics
@nl
prefLabel
Pharmacogenetics and Genomics
@ast
Pharmacogenetics and Genomics
@da
Pharmacogenetics and Genomics
@de
Pharmacogenetics and Genomics
@en
Pharmacogenetics and Genomics
@es
Pharmacogenetics and Genomics
@fi
Pharmacogenetics and Genomics
@fr
Pharmacogenetics and Genomics
@it
Pharmacogenetics and Genomics
@nb
Pharmacogenetics and Genomics
@nl
P236
P6981
P4616
P1055
P1159
P1277
P1476
Pharmacogenetics and Genomics
@en